In the present study, we characterized the in vitro modulation of NETs (neutrophil extracellular traps) induced in human neutrophils by the opportunistic fungus Cryptococcus neoformans, evaluating the participation of capsular polysaccharides glucuronoxylomanan (GXM) and glucuronoxylomannogalactan (GXMGal) in this phenomenon. The mutant acapsular strain CAP67 and the capsular polysaccharide GXMGal induced NET production. In contrast, the wild-type strain and the major polysaccharide GXM did not induce NET release. In addition, C. neoformans and the capsular polysaccharide GXM inhibited PMA-induced NET release. Additionally, we observed that the NET-enriched supernatants induced through CAP67 yeasts showed fungicidal activity on the capsular strain, and neutrophil elastase, myeloperoxidase, collagenase and histones were the key components for the induction of NET fungicidal activity. The signaling pathways associated with NET induction through the CAP67 strain were dependent on reactive oxygen species (ROS) and peptidylarginine deiminase-4 (PAD-4). Neither polysaccharide induced ROS production however both molecules blocked the production of ROS through PMA-activated neutrophils. Taken together, the results demonstrate that C. neoformans and the capsular component GXM inhibit the production of NETs in human neutrophils. This mechanism indicates a potentially new and important modulation factor for this fungal pathogen.
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In the present study, we characterized the in vitro modulation of NETs (neutrophil extracellular traps) induced in human neutrophils by the opportunistic fungus Cryptococcus neoformans, evaluating the participation of capsular polysaccharides glucuronoxylomanan (GXM) and glucuronoxylomannogalactan (GXMGal) in this phenomenon. The mutant acapsular strain CAP67 and the capsular polysaccharide GXMGal induced NET production. In contrast, the wild-type strain and the major polysaccharide GXM did not induce NET release. In addition, C. neoformans and the capsular polysaccharide GXM inhibited PMA-induced NET release. Additionally, we observed that the NET-enriched supernatants induced through CAP67 yeasts showed fungicidal activity on the capsular strain, and neutrophil elastase, myeloperoxidase, collagenase and histones were the key components for the induction of NET fungicidal activity. The signaling pathways associated with NET induction through the CAP67 strain were dependent on reactive oxygen species (ROS) and peptidylarginine deiminase-4 (PAD-4). Neither polysaccharide induced ROS production however both molecules blocked the production of ROS through PMA-activated neutrophils. Taken together, the results demonstrate that C. neoformans and the capsular component GXM inhibit the production of NETs in human neutrophils. This mechanism indicates a potentially new and important modulation factor for this fungal pathogen.
C
. neoformans is an opportunistic fungal pathogen of global distribution, which grows predominantly in the form of yeast and has a polysaccharide capsule that differentiates this microorganism from other pathogenic fungi. Cryptococcosis is prevalent in individuals with T cell deficiencies, such as those infected with HIV 1 . The capsular polysaccharide is the most well-studied structure of C. neoformans and is considered a major virulence factor 2 . In a murine experimental model, acapsular mutants are either incapable of inducing cryptococcosis or exhibit reduced virulence 3, 4 . Biochemical studies have shown that the C. neoformans capsule primarily comprises glucuronoxylomannan (GXM), representing approximately 88% of the capsule. GXM is a polymer that consists mostly of a linear a-(1-3)-mannan substituted with b-(1-2)-glucopyranosyluronic acid and b-(1-4)-xylopyranosyl. O-acetylation occurs on the C-6 of about half of the mannose residues 5, 6 . Several studies have described GXM interactions with immune cells 7 . Macrophages accumulate large amounts of GXM over long period of time in vitro, and, in contrast, neutrophils accumulating smaller amounts over a shorter time, indicating potential differences in receptor recognition and GXM digestion 7 . It has been suggested that GXM induces L-selectin shedding 8 and C5aR expression in neutrophils 9 . The C. neoformans capsule also comprises 10% glucuronoxylomannogalactan (GXMGal) and 2% mannoproteins. The GXMGal consists of an a-(1R6)-galactan backbone with galactomannan side chains that are further substituted with variable numbers of xylose and glucuronic acid residues 10 .
GXMGal induces the expression of Fas-L and apoptosis in murine peritoneal macrophages and is a more efficient polysaccharide regarding nitric oxide (NO) induction and TNF-a secretion 11 . Neutrophils are critical effector cells of the innate immune system, which are rapidly recruited to sites of inflammation and exert protective or pathogenic effects, depending on the inflammatory milieu. Neutrophils kill C. neoformans primarily via NADPH oxidasemediated ROS production 12, 13 . Consistently, neutrophils from chronic granulomatous disease (GCD) patients, which exhibit defective ROS production, do not kill these pathogens, although the phagocytosis of the fungus occurs 14 . In addition, neutrophils combat pathogens through the release of neutrophil extracellular traps (NETs), comprising decondensed chromatin associated with granular and cytosolic proteins 15 . NETs retain and kill microorganisms and restrict tissue damage caused by neutrophil microbicidal molecules associated with these scaffolds. Different microorganisms, such as bacteria, fungi, protozoa and viruses induce NET release [15] [16] [17] [18] . Among fungi, Candida albicans, Aspergillus fumigatus, Aspergillus nidulans and Cryptococcus gattii induce NET release and are susceptible to its fungicidal effects [18] [19] [20] [21] [22] . The mechanisms of NET induction are not fully understood. Chromatin decondensation has been associated with the citrullination of histones through peptidylarginine deiminase-4 (PAD4) [23] [24] [25] . In addition, both neutrophil elastase (NE) and myeloperoxidase are required for NET formation 14 . Moreover, another key stimuli for NET production are ROS generation through NADPH oxidase 19 . In the present study, we provided the first description of the in vitro modulation of NET formation by C. neoformans, evaluating the participation of its capsular polysaccharides, GXM and GXMGal, in human neutrophils. The acapsular strain CAP67 and the polysaccharide GXMGal induced NET release. In contrast, wild-type C. neoformans and its polysaccharide GXM were unable to induce NET formation and inhibited NET release.
Results
Acapsular Cryptococcus neoformans induces NET release. NET induction by C. neoformans was evaluated in both wild-type (B3501 strain) and acapsular (CAP67 mutant strain) fungi. The model was based on the in vitro interaction of neutrophils with the yeasts for 90 min, followed by the evaluation of the NET-DNA concentration in the supernatant. Although wild-type C. neoformans did not induce NET release, the acapsular strain was a potent inducer of this process (Figure 1) . PMA, which was used as a control, also induced NET release ( Figure 1) . Next, we characterized the induction of NET induced by wild-type and mutant C. neoformans strains through the labeling of DNA with DAPI and NET-associated proteins with specific antibodies (Figure 2 ). We observed that acapsular mutant CAP67 yeasts ensnared by classical NET meshes were labeled with DAPI and anti-elastase and anti-myeloperoxidase antibodies ( Figure 2B -E). Consistent with the DNA quantification, NETs were not observed with wild-type C. neoformans ( Figure 2F-J) . No labeling could be observed with secondary antibodies alone (data not shown). Similarly, NET scaffolds were not observed in the wild-type C. neoformans interaction with neutrophils ( Figure 2K ), contrary to interactions with acapsular mutant CAP67 yeasts, which were trapped by NETs as depicted through scanning electron microscopy ( Figure 2L ).
CAP67-induced NET production is dependent on ROS and PAD-4. NET release involves the production of reactive oxygen species (ROS) generated through NADPH oxidase. Thus, we investigated the role of ROS on NET release induced through CAP67 yeasts after pretreating the neutrophils with DPI, which is an inhibitor of NADPH oxidase. The results showed that NET induction was inhibited 66% following DPI treatment of neutrophils ( Figure 3A) . Peptidylarginine deiminase-4 (PAD-4) is another important enzyme associated with NET release. The addition of the PAD-4 inhibitor chloro-amidine (ClA) also inhibited 57% of the NET release induced through acapsular CAP67 yeasts ( Figure 3A) . Consistently, DHR and H2DCFDA probes revealed that acapsular mutant CAP67 yeasts induced ROS production in neutrophils ( Figure 3B and 3C) . Regardless of the probe used, ROS production was significantly decreased in the presence of DPI ( Figure 3B and 3C). Treatment with either DPI or ClA was not toxic to neutrophils, as measured by LDH release ( Figure 3D ).
The capsular polysaccharide GXM inhibited NET production in neutrophils. Wild-type yeast failed to induce NET and also inhibited NET formation induced by PMA ( Figure 4A ). We therefore, evaluated the ability of GXM, the polysaccharide purified from wild-type yeast capsules, to modulate NET release. The results demonstrated that GXM did not induce NET release, even at higher concentrations were used. Moreover, GXM inhibited NET induction through PMA ( Figure 4B ). The addition of purified GXM inhibited NET formation induced by acapsular CAP67 strain ( Figure 4C ) and Leishmania amazonensis promastigotes ( Supplementary Fig. S1 ). Inhibition of NET formation by GXM was correlated with the modulation of ROS production ( Figure 4D ). Therefore, the addition of GXM to neutrophils stimulated with PMA inhibited approximately 25% of ROS production. The ability of GXM to inhibit NET formation by neutrophils was investigated in cultures stimulated with PMA in the presence of Sytox Green, a DNA-specific dye. NET formation induced by PMA ( Figure 5A -C) was markedly inhibited after treating neutrophils with GXM for 30 min ( Figure 5D -F). Interestingly, although GXM did not induce NET release, this polysaccharide was phagocytosed by neutrophils, as revealed through intracellular staining with an anti-GXM monoclonal antibody ( Supplementary Fig. S2 ).
Staining with DAPI, anti-elastase and anti-MPO antibodies revealed that purified polysaccharide GXMGal, triggered NET release ( Figure 6A -E). Furthermore, GXMGal induced NET release in a dose-dependent manner ( Figure 6F ). Although unable to affect NET release induced by PMA, GXMGal potentiated NET release induced by L. amazonensis ( Supplementary Fig. S1) .
Surprisingly, GXMGal failed to induce ROS production ( Figure 6G ), suggesting a ROS-independent mechanism of NET release. Similar to GXM, GXMGal inhibited the production of ROS induced by PMA ( Figure 4B ). LDH release experiments showed that neither GXM nor GXMGal were toxic to neutrophils at the concentrations used in this study ( Supplementary Fig. S3A ).
NET production by human neutrophils exhibits fungicidal activity. The fungicidal activity of the released NET was evaluated on wildtype yeasts using previously induced NET-enriched supernatants. To determine the fungicidal activity of NETs, the viability of wild-type fungi was evaluated after incubation with NETs for 18 h using live and dead probes specific for yeast. The results demonstrated that only fungi treated with NETs died, as the probe was not metabolized under these conditions (i.e., changing from green to red), indicating cell death ( Figure 7A-H) .
These results demonstrated that although wild-type B3501 yeasts did not induce NET release, they suffered the fungicidal effect of NET-rich supernatants previously induced by PMA or acapsular CAP67 yeasts. Thus, NET-enriched supernatants induced by PMA or CAP67 reduced the number of B3501 colony forming units 80% and 54%, respectively ( Figure 7I ). Supernatants generated by B3501-stimulated neutrophils did not affect the number of CFU, as this yeast did not induce NET release. The disruption of the NET scaffold using DNAse abolished the observed fungicidal effects ( Figure 7I ). The increased growth of wildtype yeast was observed after DNAse treatment of NET-enriched supernatants induced through PMA and CAP67. However, supernatants from control un-stimulated neutrophils incubated or not with DNAse did not show fungicidal activity ( Figure 7I ).
To better characterize the fungicidal effect, wild-type yeasts were treated with NET-enriched supernatants in the presence of different neutralizing reagents for 18 h, and the CFU was determined. Inhibition of elastase, myeloperoxidase, collagenase and histone significantly reversed the toxicity of NETs on the growth of wild-type yeast ( Figure 7J-M) . In addition, the results of the XTT assay showed that no direct cytotoxicity of the inhibitors on the fungus (Supplementary Figure 3B) .
Discussion
Neutrophils play an essential role in host defense against fungi, and patients with decreased number or function of these cells are predis- posed to fungal infections. The increased survival of C. neoformansinfected mice after treatment with G-CSF has been previously reported 26 . Conversely, neutrophil depletion (around two days) reduces susceptibility to pulmonary cryptococcosis, indicating that this fungus somehow modulates the response of neutrophils, reducing the microbicide potential of these cells during lung infection 27 . Among the antifungal strategies of neutrophils, NET formation plays an important role, as C. albicans, A. fumigatus, A. nidulans and C. gattii induce the formation of NETs, in which these organisms are subsequently trapped and killed 18, 19, 21, 22, 28 . In addition, aspergillosis is the leading cause of death in patients with chronic granulomatous disease (CGD), in which neutrophils are unable to release NETs 28, 29 . It has also been reported that NET formation was restored through gene therapy in a CGD patient, leading to the remediation of refractory invasive aspergillosis 19 . Although a role for NETs has been described for some fungi, few species have been analyzed. Thus, the aim of the present study was to investigate the role of this mechanism for C. neoformans.
The results reported here demonstrated that only acapsular C. neoformans strain induces NET release by human neutrophils. NET structures, were identified as DNA-containing scaffolds associated with elastase and MPO. The ultrastructural features of NETensnared acapsular CAP67 yeasts were also observed using scanning electron microscopy. The wild-type C. neoformans strain did not induce NET release, as NET-DNA was not detected in neutrophilyeast culture supernatants or evidenced through immunofluorescence and scanning electron microscopy.
Most of the stimuli that trigger NET release indicate a dependency of oxidative stress generated by the NADPH oxidase 19, [30] [31] [32] . Thus, reactive oxygen species induced through this multienzyme complex are also involved in NET induction by CAP67 yeasts, as NET release by these mutant yeasts is inhibited using DPI. Another crucial step in NET extrusion is chromatin decondensation, which depends on peptidylarginine deiminase-4 (PAD-4)-mediated citrullination of histones 24, 25 . Herein, we provided the first demonstration of the involvement of PAD-4 in NET formation triggered by C. neoformans, as NET release induced by the acapsular CAP67 mutant was significantly reduced using the enzyme inhibitor chloro-amidine. Consistent with these observations, previous studies have shown that PMA-stimulated NETosis was also reduced through PAD-4 inhibition 33 . Our data undoubtedly demonstrated that the NET produced by human neutrophils kills C. neoformans because we used a system that ensures yeast viability or death, based on mitochondrial activity. Urban and colleagues previously suggested NET toxicity to C. neoformans 18 . However, in this study, it was unclear whether the fungus was dead or whether growth was paralyzed through a fungistatic effect. Thus, we used a two-color fluorescent probe to assess yeast viability, and the results showed that NETs exert clear fungicidal activity on C. neoformans, suggesting that both the plasma membrane integrity and metabolic function are affected through NETs. Moreover, we showed that colony-forming units of C. neoformans were significantly decreased after treatment with NET-enriched supernatants obtained from different sources.
Other relevant information included the identification of NETassociated molecules responsible for the fungicidal properties of these structures. These data demonstrated that the killing of C. neo- formans decreased when NET-enriched supernatants were treated with MPO, collagenase and elastase inhibitors. We also showed that histones participate in NET-mediated killing, as a histone-blocking antibody reverted C. neoformans killing. These findings indicate that the fungicidal process results from the engagement of several molecules acting cooperatively.
Interestingly, we also observed that the mutant acapsular strain CAP67 and the polysaccharide GXMGal induced the production of NET. It is possible that GXMGal is the prominent polysaccharide in the mutant strain capsule, been responsible for NET induction. Moreover, NET induction by GXMGal seems to occur in a ROS independent way, as this capsular polysaccharide does not induce the production of ROS in neutrophils. Stimuli that induce NET production without the participation of ROS have been described 24, 34, 35 , although the signaling pathways associated with ROS-independent NET production have yet to be clarified 24, 34, 35 . It was also demonstrated that C. albicans b-glucans induce NET formation by a ROS-independent mechanism, utilizing fibronectin and ERK-signaling pathways through complement receptor 3 (CD11b/ CD18) 36 . Thus, further studies regarding the signaling pathways and receptors associated with the production of NET induction through GXMGal are needed. We also observed that GXMGal acts through the inhibition of ROS production by neutrophils activated by PMA. This finding supports the hypothesis that the role of NET induction by GXMGal is independent of ROS production.
In the present study, we evaluated the in vitro interaction between neutrophils and C. neoformans to determine a role for the capsular polysaccharide GXM. In addition to not inducing NET formation, purified GXM inhibited the production of neutrophil extracellular traps stimulated through different inducers. Recently, Springer and colleagues 21 demonstrated (assessed only by scanning electron microscopy) that a not virulent mutant (deficient in the gene CAP59, associated with production of polysaccharide capsule) produced more NETs than wild-type fungus in a model of Cryptococcus gattii-neutrophil interaction, which only induced the rudimentary production of NET. These findings are consistent with experiments using C. neoformans, where the acapsular mutant strain CAP67 induced NET and the wild-type yeast did not. Therefore, it is likely that the polysaccharide capsule acts negatively in the modulation of NET production. Indeed, this property adds a new function for virulent wild-type C. neoformans as an inhibitor of NET formation through the GXM capsular polysaccharide. The inhibition of NET through GXM is significant, as this effect constitutes an escape mechanism evolved by C. neoformans. Furthermore, there are few descriptions of microorganism molecules that modulate NETs killing and/or trapping properties, such as the production of DNases [37] [38] [39] [40] , proteases 41 and the protein hydrophobin RodA from A. fumigatus 20 . Thus, NET-inhibition by C. neoformans could contribute to the dissemination and disease severity of this fungus. GXM has demonstrated regulatory action on the immune system, specifically for the treatment of other autoimmune diseases, such as rheumatoid arthritis (RA). In a murine model of RA, induced by type II collagen, the treatment of animals with GXM improved the prognosis of disease 42 . Currently, NETosis has been associated with different autoimmune conditions, with great emphasis on the pathophysiology of Systemic Lupus Erythematosus (SLE) 43 . Therefore, it is possible that GXM directly acts on neutrophils and modulates the production of NETs in patients with SLE or other pathologies associated with NETs, such as vasculitis and deep vein thrombosis 44 . In summary, the capsular polysaccharide GXM has a potential role as a therapeutic tool, which deserves further investigation.
Methods
Cryptococcus strains. Cryptococcus neoformans wild-type (B3501) and GXM negative (CAP67) 45 strains were cultured in defined medium 46 , for 48 h at 37uC with continuous shaking (100 rpm). The yeasts were washed twice, resuspended in RPMI 1640 medium and used at neutrophil/fungus ratios of 151, 155 or 1510.
Capsular polysaccharide purification. Purification procedures were adapted from protocols established for the isolation and purification of GXMGal from culture supernatant of GXM negative C. neoformans Cap 67 strain 6 , and GXM from encapsulate strains 47 . Briefly, cells grown in defined liquid medium 48 at 37uC with continuous shaking (100 rpm) for 5 days were removed through centrifugation (12, 000 g for 1 h at 4uC) , and the capsular polysaccharides in the supernatant were precipitated after adding three volumes of cold ethanol. To separate GXMGal from mannoproteins, the capsular polysaccharides were fractionated using lectin-affinity chromatography on a XK-26 column (Pharmacia) packed with 70 mL Concanavalin A-Sepharose 4B (Pharmacia) at 4uC. The unbound polysaccharide fractions, containing GXMGal, were localized through a phenol-sulfuric reaction 49 , pooled, dialyzed against distilled water and lyophilized. Pure GXMGal was obtained through anion-exchange chromatography on a MonoQ (HR16/10) column using a 50 mL superloop 49 . GXM was purified by differential precipitation with CTAB 47 . Briefly, capsular polysaccharides isolated from the culture supernatant by precipitation with ethanol were dissolved in 0.2 M NaCl (10 mg ml-1) and CTAB (3 mg mg-1 of polysaccharides) was added slowly. Then, a solution of 0.05% CTAB was added and the GXM was selectively precipitated. The precipitate was collected by centrifugation and washed with 2% acetic acid in ethanol then in 90% ethanol. The precipitate was dissolved in 1 MNaCl and three volumes of ethanol were added to precipitate the GXM. The precipitate was centrifuged, washed with 2% acetic acid in ethanol and then with ethanol, dissolved in water and lyophilized.
To eliminate potential LPS contamination, 10 mg of GXMGal or GXM preparations were dissolved in LPS-free water and further purified through chromatography on a column of Polimixin B-Agarose (Sigma) equilibrated with LPS free-water. Purified GXMGal or GXM were eluted with 12 mL of LPS free-water, recovered and lyophilized.
Neutrophil isolation. Human neutrophils from healthy donors were isolated through density gradient centrifugation (Histopaque; Sigma), followed by the hypotonic lysis of erythrocytes. Purified neutrophils ($ 95% purity) were maintained on ice until further use. Blood samples were collected from subjects after obtaining informed consent, in accordance with the Declaration of Helsinki, and approval was obtained from the ethical review board.
Quantification of NET Release. Neutrophils (10 6 ) were incubated with or without 100 nM PMA (Calbiochem), C. neoformans (B3501 and CAP67) and capsular polysaccharides (GXM or GXMGal) at different neutrophil/fungus ratios and polysaccharide concentrations. After 1 h, restriction enzymes (ECOR1 and HINDIII, 20 mnits/mL each, BioLabs) were added to the cultures, followed by incubation for 30 min at 35uC. NET-DNA was quantified in the culture supernatant using the Picogreen dsDNA Kit (Invitrogen) according to the manufacturer's instructions.
Immunofluorescence. Neutrophils were incubated with or without C. neoformans (B3501 and CAP67), PMA, GXM or GXMGal for 1 h and 30 min, followed by fixation with 4% paraformaldehyde. The slides were stained with DAPI (Sigma), anti-GXM (10 mg/mL; mAb 18B7), anti-elastase (Genetex), or anti-myeloperoxidase antibodies (Genetex), followed by anti-rabbit-FITC (Vector Labs) or anti-mouseTexas red (Molecular Probes). In some experiments, live neutrophils (treated or not with GXMor PMA) were stained with Sytox Green (Invitrogen), a DNA-specific vital dye. The epifluorescence was evaluated using a Zeiss Axioplan microscope.
Scanning electron microscopy. Adhered neutrophils on coverslips treated with 0.01% poly-L-lysine were incubated with C. neoformans (B3501or CAP67) at a 551 ratio for 90 min at 35uC, 5% CO 2 . The cultures were fixed using 2.5% glutaraldehyde in 0.1 M cacodylate buffer, pH 7.2, followed by postfixation with 1% osmium tetroxide and 0.8% potassium ferricyanide and dehydration with an ascending ethanol series. After dehydration and critical point drying, the specimens were coated with gold and analyzed using a JEOL 1530 scanning electron microscope.
Fungicidal activity of NET-enriched supernatants. NET-enriched supernatants were produced after treating neutrophils (10 6 /100 mL) with 100 nM PMA for 3 h at 35uC, 5% CO 2 , accordingly to Guimarães-Costa et al (2014) 50 . The neutrophils were subsequently centrifuged, and the NET-DNA was quantified in the supernatants and used at 2500 ng/mL throughout this study. To examine fungicidal activity, the yeasts (10 6 ) were incubated for 20 h at 37uC with NET-enriched supernatants with or without the following reagents: elastase inhibitor III (10 mg/mL), myeloperoxidase inhibitor (1 mg/mL), collagenase inhibitor I (1 mg/ml), mAb anti-histone (5 mg/mL) or DNAse (2U). Subsequently, the cells were 151000 diluted and plated on Sabouraud agar for CFU quantification after 48 h of growth at 30uC. NET-enriched supernatants were also added to 10 6 wild-type fungus for 24 h, and fungicidal activity was evaluated using a Live/Dead assay specific for yeasts according to the manufacturer's instructions (Molecular Probes).
ROS detection. Neutrophils (10 6 ) were preincubated with diphenylene iodonium (DPI, 10 mg/mL, Sigma) for 30 min at 37uC in 5% CO 2 . Subsequently, 2 mM DHR 123 (Sigma) or 10 mM H2DCFDA (Sigma) were added for 15 min, followed by washing. Subsequently, the neutrophils were stimulated with PMA (100 nM), B3501or CAP67 (both at a 155 neutrophil/yeast ratio), GXM (50 mg/mL) or GXMGal (50 mg/mL) for 15 min at 37uC in 5% CO 2 . The fluorescence intensity of the cells was analyzed using a spectramax reader at 485/538 nm (Molecular Devices).
Cytotoxicity assay. The neutrophils were incubated with various inhibitors in 96-well plates. Cell viability was tested using the CytoToxH Kit (Promega), which assesses the activity of lactate dehydrogenase released from damaged cells.
Statistical Analysis. Statistical comparisons were performed using Graphpad 5.0 software. Paired comparisons between different groups were performed using Student's t test. Each experiment was performed at least 3 times on independent occasions. P # 0.05 was considered significant. 
